Company Close Updates

Aug. 9, 2022, 4:31 p.m. EDT

Moderna Inc. stock underperforms Tuesday when compared to competitors

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) shed 6.45% to $171.14 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index (NASDAQ:COMP) falling 1.19% to 12,493.93 and Dow Jones Industrial Average (DOW:DJIA) falling 0.18% to 32,774.41. This was the stock's third consecutive day of losses. Moderna Inc. closed $326.35 short of its 52-week high ($497.49), which the company achieved on August 10th.

The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (NYS:ABBV) fell 0.06% to $140.25, Amgen Inc. (NAS:AMGN) rose 0.43% to $248.36, and AstraZeneca PLC ADR (NAS:AZN) rose 1.18% to $65.89. Trading volume (5.1 M) remained 187,742 below its 50-day average volume of 5.3 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.